Hypertension Clinical Trial
— BingocizeOfficial title:
Bingocize: A Novel Mobile Application to Help Maintain or Improve Older Adults' Health, Function, and Cognition
Verified date | February 2024 |
Source | Western Kentucky University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study tests the effectiveness of using a new mobile application (Bingocize®) to improve older adults' (a) adherence to an engaging exercise program, and (b) aspects of functional performance, health knowledge, dietary habits, and cognition.
Status | Completed |
Enrollment | 241 |
Est. completion date | May 13, 2022 |
Est. primary completion date | May 13, 2022 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 60 Years to 85 Years |
Eligibility | Inclusion Criteria: - Normal or corrected normal vision - Mobility (i.e., not wheelchair bound) - English is native language - Minimum physical standards (e.g., ability to walk at least 10 meters) - No structured physical activity programs >150 minutes/week in last 6 months Exclusion Criteria: - Severe neurological impairments (e.g., Parkinson's) - Colorblindness - Dementia |
Country | Name | City | State |
---|---|---|---|
United States | Webster County Senior Center | Dixon | Kentucky |
United States | Chester County Senior Center | Henderson | Tennessee |
United States | Johnson County Senior Center | Johnson City | Tennessee |
United States | Scotts Hill Senior Center | Scotts Hill | Tennessee |
Lead Sponsor | Collaborator |
---|---|
Western Kentucky University | National Institute on Aging (NIA) |
United States,
Kramer JH, Mungas D, Possin KL, Rankin KP, Boxer AL, Rosen HJ, Bostrom A, Sinha L, Berhel A, Widmeyer M. NIH EXAMINER: conceptualization and development of an executive function battery. J Int Neuropsychol Soc. 2014 Jan;20(1):11-9. doi: 10.1017/S135561771 — View Citation
Tinetti ME, Richman D, Powell L. Falls efficacy as a measure of fear of falling. J Gerontol. 1990 Nov;45(6):P239-43. doi: 10.1093/geronj/45.6.p239. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Executive Function Inhibition Measure 1: Flanker Task | Flanker Task designed to measure inhibition, part of the EXAMINER Battery (for scoring method, see References section). EXAMINER generates a score that combines reaction time and accuracy data from the incongruent trials. This scoring method generates accuracy and reaction time sub-scales that range in value between 0 and 5, and the ultimate composite score ranges in value between 0 and 10.
Minimum=0, Maximum=10, higher = better. |
Baseline and 12 Weeks | |
Primary | Executive Function Measure: Updating Verbal Working Memory | Dot Counting Task designed to measure verbal working memory, part of the EXAMINER Battery (for scoring method, see References). EXAMINER generates a score is the total number of items correctly recalled across all six trials.
Minimum=0, Maximum=27, higher = better. |
Baseline and 12 Weeks | |
Primary | Executive Function Measure: Set Shifting Task | Set Shifting Task designed to measure attention during task switching, part of the EXAMINER Battery (for scoring method, see References). EXAMINER generates a score that combines reaction time and accuracy data from the incongruent trials. This scoring method generates accuracy and reaction time sub-scales that range in value between 0 and 5, and the ultimate composite score ranges in value between 0 and 10.
Minimum=0, Maximum=10, higher = better. |
Baseline and 12 Weeks | |
Primary | Executive Function Measure: Verbal Fluency | Verbal Fluency Task designed to measure fluency, part of the EXAMINER Battery (for scoring method, see References). EXAMINER generates a score that represents the total number of words correctly recalled in two tasks: phonemic (letter) and semantic (category).
Minimum=0, Maximum=unlimited, higher = better. |
Baseline and 12 Weeks | |
Primary | Chair Stands: Change in Lower-body Muscular Strength | number of completed chair stands in 30 seconds, minimum=0, higher = better | Baseline and 12 Weeks | |
Primary | Change in Dynamic Balance: 360 Degree Turns | 360 degree turns: time to complete. No minimum or maximum value set. Lower = better. | Baseline and 12 Weeks | |
Primary | Executive Function Measure of Inhibition: Continuous Performance Test | Continuance Performance Task is classic response inhibition task, part of the EXAMINER Battery (for scoring method, see References). The score here represents the number of trials out of 100 that the participant responded correctly (i.e., either successfully responded or successfully inhibited a response).
Minimum=0 Maximum=100, higher = better. |
Baseline and 12 Weeks | |
Primary | Timed Up and Go (TUG) Test: Change in Dynamic Balance | Timed Up and Go (TUG) Test used to assess mobility and risk for falling. Number of seconds needed to stand up from a chair, walk 10 feet, turn around, walk back 10 feet, and sit back down in chair. No minimum or maximum value is set. Lower = better. | Baseline and 12 Weeks | |
Secondary | Crystallized Knowledge of Fall Risks and Proper Diet/Nutrition | Multiple-choice questions constructed by project investigators that cover: recognition of health terms, weight management, proper diet, bone health, environmental fall risks, careful movement. Unit of measure = number correct. Minimum = 0, Maximum = 30. Higher = better. | Baseline and 12 Weeks | |
Secondary | Grip Strength: Changes in Upper Body Muscular Strength | Grip strength tests using a hand-held dynamometer. No minimum or maximum set. Higher = better. | Baseline and 12 Weeks | |
Secondary | Fall Efficacy Scale | Self-reported scale assessing confidence in doing activities that may be perceived as having risk for falling (see References).
Minimum = 10, Maximum = 100. Lower = better. |
Baseline and 12 Weeks | |
Secondary | Changes in Dietary Habits: Total Added Sugar Intake | Dietary Screener Questionnaire (DSQ) assessing total added sugar intake over past 30 days | Baseline and 12 Weeks | |
Secondary | Changes in Quality of Life | CDC Health related quality of life measure item 1 (general health). 1 = Excellent, 5 = Poor. Lower = Better. | Baseline and 12 Weeks | |
Secondary | Changes in Weight | Weight calculated by scale measurement | Baseline and 12 Weeks | |
Secondary | Systolic Blood Pressure | Systolic Blood pressure calculated by sphygmomanometer. | Baseline and 12 Weeks | |
Secondary | Diastolic Blood Pressure | Diastolic Blood pressure calculated by sphygmomanometer | Baseline and 12 Weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT04591808 -
Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia
|
Phase 3 | |
Recruiting |
NCT04515303 -
Digital Intervention Participation in DASH
|
||
Completed |
NCT05433233 -
Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension
|
N/A | |
Completed |
NCT05491642 -
A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses
|
Phase 1 | |
Completed |
NCT03093532 -
A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Completed |
NCT05529147 -
The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
|
||
Recruiting |
NCT06363097 -
Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
|
||
Recruiting |
NCT05976230 -
Special Drug Use Surveillance of Entresto Tablets (Hypertension)
|
||
Completed |
NCT06008015 -
A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT05387174 -
Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period
|
N/A | |
Completed |
NCT04082585 -
Total Health Improvement Program Research Project
|
||
Recruiting |
NCT05121337 -
Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension
|
N/A | |
Withdrawn |
NCT04922424 -
Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men
|
Phase 1 | |
Active, not recruiting |
NCT05062161 -
Sleep Duration and Blood Pressure During Sleep
|
N/A | |
Completed |
NCT05087290 -
LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
|
||
Not yet recruiting |
NCT05038774 -
Educational Intervention for Hypertension Management
|
N/A | |
Completed |
NCT05621694 -
Exploring Oxytocin Response to Meditative Movement
|
N/A | |
Completed |
NCT05688917 -
Green Coffee Effect on Metabolic Syndrome
|
N/A | |
Recruiting |
NCT05575453 -
OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure
|
N/A |